RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Orion Oyj Stock

Orion Oyj Stocks 2024

Orion Oyj Stocks

140.36 M

Ticker

ORNBV.HE

ISIN

FI0009014377

WKN

A0J3QM

In 2024, Orion Oyj had 140.36 M outstanding stocks, a 0% change from the 140.36 M stocks in the previous year.

The Orion Oyj Stocks history

YEARNUMBER OF STOCKS (undefined EUR)
2029e140.36
2028e140.36
2027e140.36
2026e140.36
2025e140.36
2024e140.36
2023140.36
2022140.59
2021140.55
2020140.51
2019140.57
2018140.68
2017140.57
2016140.67
2015140.81
2014140.7
2013141
2012140.9
2011140.8
2010140.9
2009141
2008141
2007141.3
2006140.6
2005141.3
2004141.3

Orion Oyj shares outstanding

The number of shares was Orion Oyj in 2023 — This indicates how many shares 140.361 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Orion Oyj earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Orion Oyj's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Orion Oyj’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Orion Oyj's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Orion Oyj Aktienanalyse

What does Orion Oyj do?

Orion Oyj is a Finnish company that was founded in 1917 as a pharmacy in Turku. Today, Orion Oyj is a leading manufacturer of diagnostic tests, medicines, and other health products. Business model: Orion Oyj focuses on four core areas: Pharmaceutical, Diagnostics, Animal Health, and Fermion. The Pharmaceutical segment is the largest market and includes the production and sale of prescription drugs in the therapy areas of central nervous system disorders, oncology, respiratory diseases, and urology. Orion also produces generics of prescription drugs. The Diagnostics segment includes the development and production of in vitro diagnostic tests (IVDs) for clinical laboratories and point-of-care facilities. Animal Health manufactures products for animal health. Fermion produces active ingredients and intermediates for use in Orion's own and other pharmaceutical companies. Products: Orion offers a wide range of health products. The key products in the pharmaceutical segment are levodopa-based Parkinson's drugs (Stalevo, Comtess, and Opicapone) and drugs for the treatment of asthma and chronic obstructive pulmonary diseases (Easyhaler product family). ORIAHNN (Eligolix and estradiol capsules) was approved by the FDA as the first oral medication for the treatment of uterine fibroids in premenopausal women. In animal health, Orion Oyj offers products focused on the treatment of pet skin diseases, eye and ear infections, and parasite infestations. Orion also has a wide range of IVD products. The focus is on infection diagnostics, offering a wide range of medical tests to detect infections such as hepatitis B, hepatitis C, HIV, tuberculosis, human papillomavirus, and other sexually transmitted diseases. In the diagnostics segment, Orion also produces devices used in blood tests and other tests in hospitals and clinical laboratories. Future prospects: Orion Oyj is expected to invest more in the IVD segment in the coming years. The company sees significant growth potential here and plans to launch new products and test kits on the market. In addition, Orion also invests in spin-off companies focusing on the research and development of promising new technologies and therapies. Orion Oyj has been a leading player in the healthcare market for years. With a wide range of products and a strong focus on research and development, the company has built a solid foundation for future success. Orion Oyj ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Orion Oyj's Shares Outstanding

Orion Oyj's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Orion Oyj’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Orion Oyj’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Orion Oyj’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Orion Oyj stock

How many stocks are there of Orion Oyj?

The current number of stocks of Orion Oyj is 140.36 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Orion Oyj are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Orion Oyj evolved in recent years?

The number of shares of Orion Oyj has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Orion Oyj as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Orion Oyj?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Orion Oyj pay?

Over the past 12 months, Orion Oyj paid a dividend of 1.6 EUR . This corresponds to a dividend yield of about 3.25 %. For the coming 12 months, Orion Oyj is expected to pay a dividend of 1.73 EUR.

What is the dividend yield of Orion Oyj?

The current dividend yield of Orion Oyj is 3.25 %.

When does Orion Oyj pay dividends?

Orion Oyj pays a quarterly dividend. This is distributed in the months of April, April, April, November.

How secure is the dividend of Orion Oyj?

Orion Oyj paid dividends every year for the past 23 years.

What is the dividend of Orion Oyj?

For the upcoming 12 months, dividends amounting to 1.73 EUR are expected. This corresponds to a dividend yield of 3.52 %.

In which sector is Orion Oyj located?

Orion Oyj is assigned to the 'Health' sector.

Wann musste ich die Aktien von Orion Oyj kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Orion Oyj from 10/23/2024 amounting to 0.81 EUR, you needed to have the stock in your portfolio before the ex-date on 10/15/2024.

When did Orion Oyj pay the last dividend?

The last dividend was paid out on 10/23/2024.

What was the dividend of Orion Oyj in the year 2023?

In the year 2023, Orion Oyj distributed 1.5 EUR as dividends.

In which currency does Orion Oyj pay out the dividend?

The dividends of Orion Oyj are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Orion Oyj

Our stock analysis for Orion Oyj Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orion Oyj Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.